Published in:
Open Access
01-09-2014 | Poster presentation
Prescribed but not approved: biologic agents used without approval in juvenile idiopathic arthritis in Switzerland, France and Belgium
Authors:
Andreas Woerner, Alexandre Belot, Etienne Merlin, Carine Wouters, Gerald Berthet, Anuela Kondi, Daniela Kaiser, Laetitia Higel, Anne Maes, Elvira Cannizzaro, Natalia Cabrera, Silke Schroeder, Florence Aeschlimann, Annette von Scheven, Agnès Duquesne, Samuel Roethlisberger, Isabelle Kone-Paut, Michael Hofer
Published in:
Pediatric Rheumatology
|
Special Issue 1/2014
Login to get access
Excerpt
Biologic agents (BA) have profoundly changed the outcome of juvenile idiopathic arthritis (JIA), making inactive disease and clinical remission an achievable goal for treatment. An increasing number of BA has become available in the last 15 years. However, some BA that have been associated to efficacy in some clinical conditions are not approved by legal authority for the use in pediatric population. …